Literature DB >> 15239655

A ligand-based approach to identify quantitative structure-activity relationships for the androgen receptor.

Casey E Bohl1, Cheng Chang, Michael L Mohler, Jiyun Chen, Duane D Miller, Peter W Swaan, James T Dalton.   

Abstract

We examined the three-dimensional quantitative structure-activity relationship (QSAR) of a group of endogenous and synthetic compounds for the androgen receptor (AR) using comparative molecular field analysis (CoMFA). The goal of these studies was to identify structural features necessary for high binding affinity and optimization of selective androgen receptor modulators (SARMs). A homology model of the AR was used as a scaffold to align six lead compounds that served as templates for alignment of the remaining 116 structures prior to CoMFA modeling. The conventional r(2) and cross-validated q(2) relating observed and predicted relative binding affinity (RBA) were 0.949 and 0.593, respectively. Comparison of predicted and observed RBA for a test set of 10 compounds resulted in an r(2) of 0.954, demonstrating the excellent predictive ability of the model. These integrated homology modeling and CoMFA studies identified critical amino acids for SARM interactions and provided QSAR data as the basis for mechanistic studies of AR structure, function, and design of optimized SARMs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15239655      PMCID: PMC2080780          DOI: 10.1021/jm0499007

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  17 in total

Review 1.  Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium.

Authors:  A Negro-Vilar
Journal:  J Clin Endocrinol Metab       Date:  1999-10       Impact factor: 5.958

2.  Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations.

Authors:  P M Matias; P Donner; R Coelho; M Thomaz; C Peixoto; S Macedo; N Otto; S Joschko; P Scholz; A Wegg; S Bäsler; M Schäfer; U Egner; M A Carrondo
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

3.  Homology modeling using multiple molecular dynamics simulations and docking studies of the human androgen receptor ligand binding domain bound to testosterone and nonsteroidal ligands.

Authors:  C A Marhefka; B M Moore; T C Bishop; L Kirkovsky; A Mukherjee; J T Dalton; D D Miller
Journal:  J Med Chem       Date:  2001-05-24       Impact factor: 7.446

4.  DrugScore meets CoMFA: adaptation of fields for molecular comparison (AFMoC) or how to tailor knowledge-based pair-potentials to a particular protein.

Authors:  Holger Gohlke; Gerhard Klebe
Journal:  J Med Chem       Date:  2002-09-12       Impact factor: 7.446

5.  Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor.

Authors:  Donghua Yin; Yali He; Minoli A Perera; Seoung Soo Hong; Craig Marhefka; Nina Stourman; Leonid Kirkovsky; Duane D Miller; James T Dalton
Journal:  Mol Pharmacol       Date:  2003-01       Impact factor: 4.436

6.  Discovery of nonsteroidal androgens.

Authors:  J T Dalton; A Mukherjee; Z Zhu; L Kirkovsky; D D Miller
Journal:  Biochem Biophys Res Commun       Date:  1998-03-06       Impact factor: 3.575

7.  Switching androgen receptor antagonists to agonists by modifying C-ring substituents on piperidino[3,2-g]quinolinone.

Authors:  L Zhi; C M Tegley; K B Marschke; T K Jones
Journal:  Bioorg Med Chem Lett       Date:  1999-04-05       Impact factor: 2.823

8.  Specific recognition of androgens by their nuclear receptor. A structure-function study.

Authors:  N Poujol; J M Wurtz; B Tahiri; S Lumbroso; J C Nicolas; D Moras; C Sultan
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

9.  Affinity labeling of the androgen receptor with nonsteroidal chemoaffinity ligands.

Authors:  A Mukherjee; L I Kirkovsky; Y Kimura; M M Marvel; D D Miller; J T Dalton
Journal:  Biochem Pharmacol       Date:  1999-10-15       Impact factor: 5.858

10.  Novel nonsteroidal ligands with high binding affinity and potent functional activity for the androgen receptor.

Authors:  Yali He; Donghua Yin; Minoli Perera; Leonid Kirkovsky; Nina Stourman; Wei Li; James T Dalton; Duane D Miller
Journal:  Eur J Med Chem       Date:  2002-08       Impact factor: 6.514

View more
  24 in total

Review 1.  Chemistry and structural biology of androgen receptor.

Authors:  Wenqing Gao; Casey E Bohl; James T Dalton
Journal:  Chem Rev       Date:  2005-09       Impact factor: 60.622

Review 2.  Discovery and therapeutic promise of selective androgen receptor modulators.

Authors:  Jiyun Chen; Juhyun Kim; James T Dalton
Journal:  Mol Interv       Date:  2005-06

3.  Arylisothiocyanato selective androgen receptor modulators (SARMs) for prostate cancer.

Authors:  Dong Jin Hwang; Jun Yang; Huiping Xu; Igor M Rakov; Michael L Mohler; James T Dalton; Duane D Miller
Journal:  Bioorg Med Chem       Date:  2006-07-07       Impact factor: 3.641

Review 4.  Pharmacophore-based discovery of ligands for drug transporters.

Authors:  Cheng Chang; Sean Ekins; Praveen Bahadduri; Peter W Swaan
Journal:  Adv Drug Deliv Rev       Date:  2006-09-26       Impact factor: 15.470

5.  Antiandrogenic properties of parabens and other phenolic containing small molecules in personal care products.

Authors:  Jiangang Chen; Ki Chang Ahn; Nancy A Gee; Shirley J Gee; Bruce D Hammock; Bill L Lasley
Journal:  Toxicol Appl Pharmacol       Date:  2007-03-27       Impact factor: 4.219

6.  Synthesis of irreversibly binding bicalutamide analogs for imaging studies.

Authors:  Vipin A Nair; Suni M Mustafa; Michael L Mohler; Jun Yang; Leonid I Kirkovsky; James T Dalton; Duane D Miller
Journal:  Tetrahedron Lett       Date:  2005-07-11       Impact factor: 2.415

7.  Synthesis of oxazolidinedione derived bicalutamide analogs.

Authors:  Vipin A Nair; Suni M Mustafa; Michael L Mohler; James T Dalton; Duane D Miller
Journal:  Tetrahedron Lett       Date:  2006-06-05       Impact factor: 2.415

8.  Enantioselective γ-C(sp3)-H Activation of Alkyl Amines via Pd(II)/Pd(0) Catalysis.

Authors:  Qian Shao; Qing-Feng Wu; Jian He; Jin-Quan Yu
Journal:  J Am Chem Soc       Date:  2018-04-11       Impact factor: 15.419

9.  Effect of B-ring substitution pattern on binding mode of propionamide selective androgen receptor modulators.

Authors:  Casey E Bohl; Zengru Wu; Jiyun Chen; Michael L Mohler; Jun Yang; Dong Jin Hwang; Suni Mustafa; Duane D Miller; Charles E Bell; James T Dalton
Journal:  Bioorg Med Chem Lett       Date:  2008-09-05       Impact factor: 2.823

10.  Comparing Machine Learning Models for Aromatase (P450 19A1).

Authors:  Kimberley M Zorn; Daniel H Foil; Thomas R Lane; Wendy Hillwalker; David J Feifarek; Frank Jones; William D Klaren; Ashley M Brinkman; Sean Ekins
Journal:  Environ Sci Technol       Date:  2020-11-19       Impact factor: 9.028

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.